DEBENTUREHOLDERS AGREEMENT
--------------------------
THIS DEBENTUREHOLDERS AGREEMENT (this "Debentureholders Agreement") is
entered into as of December 20, 2002 by and among XXXXXX DRUG CO., INC., a
corporation organized and existing under the laws of the State of New York
("Xxxxxx" or the "Company"), and each of the holders of the Company's 5%
Convertible Senior Secured Debentures due March 31, 2006 listed on the signature
page hereto.
WHEREAS, Xxxxxx is a party to a certain Debenture and Warrant Purchase
Agreement dated as of March 10, 1998, as amended (the " 1998 Purchase
Agreement"), with the persons listed on the signature pages thereto and pursuant
to which the Company issued certain 5% Convertible Senior Secured Debentures due
March 3 1, 2006 (the " 1998 Debentures"); and
WHEREAS, Xxxxxx entered into a certain Debenture and Warrant Purchase
Agreement dated as of May 26, 1999, as amended (the "1999 Purchase Agreement"),
with the persons listed on the signature pages thereto and pursuant to which the
Company issued certain 5% Convertible Senior Secured Debentures due March 31,
2006 (the "1999 Debentures" and together with the 1998 Debentures, the "Existing
Debentures"); and
WHEREAS, the Company has concurrently herewith entered into a certain
Debenture Purchase Agreement dated as of December 20, 2002 (the "2002 Purchase
Agreement"; capitalized terms used herein but not otherwise defined herein shall
have the meanings ascribed thereto in the 2002 Purchase Agreement) with Care
Capital Investments II, LP, Essex Woodlands Health Ventures V, L.P. and those
other persons listed on the signature pages thereto and pursuant to which the
Company proposes to issue certain 5% Convertible Senior Secured Debentures due
March 31, 2006 (the "2002 Debentures" and together with the Existing Debentures,
the "Debentures"); and
WHEREAS, it is a condition to the completion of the transactions
contemplated pursuant to the 2002 Purchase Agreement that the Company shall have
executed this Debentureholders Agreement providing that the approval of the
holders of the Debentures shall be required as a condition to the Company's
completion of certain material transactions; and
WHEREAS, the Company and the holders of the Debentures desire to enter
into this Agreement to provide for the approval rights of the holders of the
Debentures as hereinafter provided.
NOW, THEREFORE, in consideration of the mutual covenants contained
herein and other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the parties hereby agree as follows:
1. Debentureholder Approval for Material Transactions.
(a) Consent of Holders of 2002 Debentures. The Company hereby
covenants and agrees, that so long as any of the 2002 Debentures
remain outstanding, it will not, directly or indirectly, without the
prior written consent of the holders of at least sixty-six and
two-thirds percent (662,3%) in the aggregate principal amount of the
2002
Debentures then outstanding, take, or permit to be taken, any of the
following actions or complete, or permit to be taken, any of the
following transactions:
(i) Any modification of the rights of the holders of the
2002 Debentures;
(ii) Any issuance of securities, or the incurrence of
indebtedness, by the Company or any Guarantor which rank senior
or equal in right of payment to the 2002 Debentures;
(iii) Any declaration or payment of any dividends or
distributions on, or redemptions of, any securities ranking
junior in priority to the 2002 Debentures, other than dividends
or distributions payable in the Company's capital stock or cash
interest paid to individual investors in the Existing Debentures;
(iv) (A) A merger, reorganization, consolidation or other
business combination involving the Company or any Guarantor, (B)
a sale, transfer, lease, license or other disposition of all or
substantially all of the assets of the Company or any Guarantor
or (C) any other similar extraordinary transaction involving the
Company or any Guarantor, in any single transaction or a series
of related transactions (the "Extraordinary Transactions"), other
than any such transaction where the cash, marketable securities
and other liquid consideration received by the holders of the
voting stock of the Company in such transaction is at least equal
to four (4) times the then applicable conversion price of the
2002 Debentures;
(v) The liquidation, dissolution, commencement of any
bankruptcy or other proceeding of the type referred to in Section
12.1(j) of the 2002 Purchase Agreement, recapitalization or
reorganization of the Company (in each case whether or not they
constitute transactions of the type referred to in Section
1(a)(vi) below); and
(vi) Without limiting the generality of Section 1 (a)(iv)
above, the consummation of a strategic alliance, Extraordinary
Transaction, licensing arrangement or other corporate partnering
arrangement involving the issuance by the Company or any
Guarantor of in excess of ten million dollars ($10,000,000) in
equity securities of the Company or any Guarantor.
(b) Consent of Holders of Debentures. Without limiting in any way
the approval rights granted to the holders of the 2002 Debentures in
Section 1(a) above, the Company hereby covenants and agrees, that so
long as any of the Debentures remain outstanding, it will not,
directly or indirectly, without the prior written consent of the
holders of at least sixty-six and two-thirds percent (662/3%) in the
aggregate principal amount of the Debentures then outstanding, take,
or permit to be taken, any of the
-2-
following actions or complete, or permit to be completed, any of the
following transactions:
(i) Any amendment to the Company's Certificate of
Incorporation;
(ii) Any declaration or payment of any dividends or
distributions on, or redemptions of, the Company's capital stock,
other than dividends or distributions payable in the Company's
capital stock or cash interest paid to individual investors in
the 2002 Debentures, the 1999 Debentures and the 1998 Debentures;
(iii) An Extraordinary Transaction; provided, however, that
(I) for purposes of calculating the consent of at least sixty-six
and two-thirds percent (662/3%) in the aggregate principal amount
of the Debentures where the cash, marketable securities and other
liquid consideration received by the holders of the voting stock
of the Company in such Extraordinary Transaction is at least
equal to four (4) times the then applicable conversion price of
(a) the 2002 Debentures, the 2002 Debentures shall be excluded,
(b) the 1999 Debentures, the 1999 Debentures shall be excluded,
and (c) the 1998 Debentures, the 1998 Debentures shall be
excluded; and (II) no prior approval or consent of the holders of
the Debentures shall be required for any Extraordinary
Transaction where the cash, marketable securities and other
liquid consideration received by the holders of the voting stock
of the Company in such Extraordinary Transaction is at least
equal to four (4) times the then highest applicable conversion
price of the Debentures;
(iv) The liquidation, dissolution, commencement of any
bankruptcy or other proceeding of the type referred to in Section
12. 1(j) of the 2002 Purchase Agreement, recapitalization or
reorganization of the Company (in each case whether or not they
constitute transactions of the type referred to in Section
l(b)(vii) below);
(v) Except as otherwise waived, any issuance of the
Company's securities which rank senior or equal in right of
payment to the Existing Debentures;
(vi) Any increase in the number of members comprising the
Company's Board of Directors above eleven (11); and
(vii) Without limiting the generality of Section 1(b)(iii)
above, the consummation of a strategic alliance, Extraordinary
Transaction, licensing arrangement or other corporate partnering
arrangement involving the issuance by the Company of in excess of
ten million dollars ($ 10,000,000) in equity securities of the
Company or any Guarantor.
2. Amendment and Waiver. Except as otherwise provided herein, no
modification, amendment or waiver of any provision of this Debentureholders
Agreement shall be effective
-3-
against the Company or the holders of the Debentures unless such modification,
amendment or waiver is approved in writing by the Company and the holders of not
less than fifty-one percent (51%) of the aggregate principal amount of the
Debentures then outstanding; provided that notwithstanding the foregoing, (a)
the prior written consent of each holder of the 2002 Debentures will be required
to amend any payment terms of the 2002 Debentures, (b) the prior written consent
of the holders of at least sixty-six and two-thirds percent (66 2/3%) in the
aggregate principal amount of the 2002 Debentures will be required to modify,
amend or waive any provision of Sections 1(a), 2(a), 2(b) and 3 of this
Debentureholders Agreement and (c) the prior written consent of the holders of
at least sixty-six and two-thirds percent (66 2/3%) in the aggregate principal
amount of the Debentures then outstanding will be required to modify, amend or
waive any provision of Section 1 (b) of this Debentureholders Agreement. The
failure of any party to enforce any of the provisions of this Debentureholders
Agreement shall in no way be construed as a waiver of such provisions and shall
not affect the right of such party thereafter to enforce each and every
provision of this Debentureholders Agreement in accordance with its terms.
3. Termination. This Debentureholders Agreement shall terminate on the
earliest to occur of (a) mutual written agreement of the parties hereto and (b)
the conversion of Debentures into the Company's Common Stock, or repayment of
the Debentures with accrued and unpaid interest, or combination of the
foregoing, such that the aggregate outstanding principal amount of the
Debentures then outstanding is less than five million dollars ($5,000,000).
4. Severability. Whenever possible, each provision of this Agreement
shall be interpreted in such manner as to be effective and valid under
applicable law, but if any provision of this Debentureholders Agreement is held
to be invalid, illegal or unenforceable in any respect under any applicable law
or rule in any jurisdiction, such invalidity, illegality or unenforceability
shall not affect any other provision or any other jurisdiction, but this
Debentureholders Agreement shall be reformed, construed and enforced in such
jurisdiction as if such invalid, illegal or unenforceable provision had never
been contained herein.
5. Entire Agreement. Except as otherwise expressly set forth herein,
this document, the 2002 Purchase Agreement, the 1998 Purchase Agreement, as
amended pursuant to the Amendment to Debenture and Warrant Purchase Agreement
dated of even date, and the 1999 Purchase Agreement, as amended pursuant to the
Amendment to Debenture and Warrant Purchase Agreement dated of even date embody
the complete agreement and understanding among the parties hereto with respect
to the subject matter hereof and supersede and preempt any prior understandings,
agreements or representations by or among the parties, written or oral, which
may have related to the subject matter hereof in any way.
6. Successors and Assigns. Except as otherwise provided herein, this
Debentureholders Agreement shall bind and inure to the benefit of and be
enforceable by the Company and its successors and assigns, and the holders of
the Debentures and any subsequent holders of the Debentures and the respective
successors and assigns of each of them, so long as they hold the Debentures.
-4-
7. Counterparts. This Debentureholders Agreement may be executed in
separate counterparts each of which shall be an original and all of which taken
together shall constitute one and the same agreement.
8. Notices. All notices, demands or other communications to be given or
delivered under or by reason of the provisions of this Debentureholders
Agreement will be in writing and will be deemed to have been given when
delivered personally, mailed by certified or registered mail, return receipt
requested and postage prepaid, or sent via a nationally recognized overnight
courier, or sent via facsimile to the recipient accompanied by a certified or
registered mailing. Such notices, demands or other communications will be sent
to the address indicated below:
To the Company:
Xxxxxx Drug Co., Inc.
000 X. Xxxxxxxxxx Xxxx
Xxxxxxxx, Xxxxxxxx 00000
Attn: President
Fax: 000-000-0000
If to the holders of the Debentures:
To the address provided
on the signature pages to
the 1998 Purchase
Agreement, 1999 Purchase
Agreement and 2002
Purchase Agreement
or such other address or to the attention of such other person as the recipient
party shall have specified by prior written notice to the sending party. Any
such notice, demand or communication shall be deemed to have been given (a) on
the date of delivery, if delivered personally, (a) on the date of facsimile
transmission, receipt confirmed, (c) one business day after delivery to a
nationally recognized overnight courier service, if marked for next day delivery
or (d) five business days after the date of mailing, if mailed.
9. Governing Law. This Debentureholders Agreement shall be governed by,
and construed in accordance with, the laws of the State of New York wherein the
terms of this Debentureholder Agreement were negotiated, excluding to the
greatest extent permitted by law any rule of law that would cause the
application of the laws of any jurisdiction other than the State of New York.
10. Jurisdiction. (a) Each of the parties hereto hereby irrevocably and
unconditionally submits, for itself and its property, to the nonexclusive
jurisdiction of any New York State court or United States Federal court sitting
in New York City, and any appellate court from any thereof, in any action or
proceeding arising our of or relating to this Debentureholders Agreement to
which it is a party, or for recognition or enforcement of any judgment, and each
of the parties hereto irrevocably and unconditionally agrees that all claims in
respect of any such action or proceeding may be heard and determined in any such
New York State court or, to the fullest extent permitted by law, in such United
States Federal court. Each of the parties hereto agrees that a final judgment in
any such action or proceeding shall be conclusive and may be
-5-
enforced in other jurisdictions by suit on the right that any party may
otherwise have to bring any action or proceeding relating to this
Debentureholders Agreement in the courts of any other jurisdiction.
(b) Each of the parties hereto irrevocably and unconditionally
waives, to the fullest extent it may legally and effectively do so,
any objection that it may now or hereafter have to the laying of venue
of any suit, action or proceeding arising out of or in relation to
this Debentureholders Agreement to which it is a party in any such New
York State or United States Federal court sitting in New York City.
Each of the parties hereto hereby irrevocably waives, to the fullest
extent permitted by law, the defense of an inconvenient forum to the
maintenance of such action or proceeding in any such court.
11. Waiver of Jury Trial. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY
WAIVES ALL RIGHT TO TRIAL BY JURY 1N ANY ACTION, PROCEEDING OR COUNTERCLAIM
(WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO
THIS DEBENTUREHOLDERS AGREEMENT OR THE ACTIONS OF ANY PARTY IN THE NEGOTIATION,
ADMINISTRATION, PERFORMANCE OR ENFORCEMENT THEREOF.
IN WITNESS WHEREOF, the parties hereto have executed this
Debentureholders Agreement as of the date first above written.
XXXXXX DRUG CO., INC.
By: /s/ Xxxxx X. Xxxxxxx
------------------------------
Name: Xxxxx X. Xxxxxxx
------------------------------
Title: VP & CFO
------------------------------
-6-
2002 DEBENTUREHOLDERS
---------------------
XXXXX PARTNERS III, L.P. GALEN PARTNERS INTERNATIONAL, III,
By: Claudius, L.L.C., General Partner L.P.
000 Xxxxx Xxxxxx, 0xx Xx. By: Claudius, L.L.C., General Partner
Xxx Xxxx, Xxx Xxxx 00000 000 Xxxxx Xxxxxx, 0xx Xx.
Xxx Xxxx, Xxx Xxxx 00000
/s/ Xxxxx Xxxxxxxxxxx /s/ Xxxxx Xxxxxxxxxxx
------------------------------ -----------------------------------
By: Xxxxx Xxxxxxxxxxx By: Xxxxx Xxxxxxxxxxx
Its: General Partner Its: General Partner
XXXXX EMPLOYEE FUND III, L.P. ESSEX WOODLANDS HEALTH
By: Wesson Enterprises, Inc. VENTURES FUND V
000 Xxxxx Xxxxxx, 0xx Xx. 000 Xxxxx XxXxxxx Xxxxxx, Xxxxx 0000
Xxx Xxxx, XX 00000 Xxxxxxx, XX 00000
/s/ Xxxxx X. Xxxxxx /s/ Xxxxxxxx Xxxxxxxxx
------------------------------ -----------------------------------
By: Xxxxx X. Xxxxxx By: Xxxxxxxx Xxxxxxxxx
Its: General Partner Its: Managing Director
CARE CAPITAL LLC XXXXXXX XXXX
00 Xxxxxxx Xxxxxx, Xxxxx 000 c/o Xxxxxx Xxxx
Xxxxxxxxx, XX 00000 000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
/s/ Xxxxx X. Xxxxxx /s/ Xxxxxxx Xxxx
------------------------------ ----------------------------------
By: Xxxxx X. Xxxxxx
Its: Partner
XXXXXXX XXXXXXXX XXXXX XXXXXXXX
0000 Xxxx Xxxxx Xxxx 0000 Xxxx Xxxxx Xxxx
Xxxxxxxx, Xxxxxxxxxxxx 00000 Xxxxxxxx, Xxxxxxxxxxxx 00000
/s/ Xxxxxxx Xxxxxxxx /s/ Xxxxx Xxxxxxxx
------------------------------ ----------------------------------
XXXX XXXX XXXXX XXXXXX
c/o D.R. International c/o Xxx Xxxxxxxx
0000 Xx. Xxxxxxxx Xxxxxx 0000 Xxxxxxx Xxxx
Xxx Xxxxxxx, Xxxxxxxxxx 00000 Xxxxx 000
Xxxxxxxx, XX 00000
/s/ Xxxx Xxxx /s/ Xxxxx Xxxxxx
------------------------------ ----------------------------------
-7-
XXXXXX X. XXXXXXXX
000 Xxxxx Xxxx
Xxxxxxxxx, XX 00000
/s/ Xxxxxx X. Xxxxxxxx
------------------------------
-8-
EXISTING DEBENTUREHOLDERS
-------------------------
ORACLE STRATEGIC PARTNERS, L.P. GALEN PARTNERS INTERNATIONAL, III,
By: Oracle Strategic Capital L.L.C., L.P.
General Partner By: Claudius, L.L.C., General Partner
000 Xxxxxxxxx Xxxxxx, 0xx Xxxxx 000 Xxxxx Xxxxxx, 0xx Xx.
Xxxxxxxxx, XX 00000 Xxx Xxxx, Xxx Xxxx 00000
/s/ Xxxx Xxxxxxxx /s/ Xxxxx Xxxxxxxxxxx
------------------------------ ----------------------------------
By: Xxxx Xxxxxxxx By: Xxxxx Xxxxxxxxxxx
Its: Authorized Agent Its: General Partner
XXXXX EMPLOYEE FUND III, L.P. GALEN PARTNERS INTERNATIONAL, III,
By: Wesson Enterprises, Inc. L.P.
000 Xxxxx Xxxxxx, 0xx Xxxxx By: Claudius, L.L.C., General Partner
Xxx Xxxx, Xxx Xxxx 00000 000 Xxxxx Xxxxxx, 0xx Xx.
Xxx Xxxx, Xxx Xxxx 00000
/s/ Xxxxx X. Xxxxxx /s/ Xxxxx Xxxxxxxxxxx
------------------------------ ----------------------------------
By: Xxxxx X. Xxxxxx By: Xxxxx Xxxxxxxxxxx
Its: General Partner Its: General Partner
XXXX XXXXX XXXXXXX XXXXX
000 Xxxxxx Xxxxxx 000 Xxxxxx Xxxxxx Xxxx
Xxxxxxx, Xxxxx Xxxxxx 00000 Xxxxxxxx, XX 00000
/s/ Xxxx xxxxx /s/ Xxxxxxx Xxxxx
------------------------------ ----------------------------------
XXXXXXX XXXXXXXX XXXXX XXXXXXXX
0000 Xxxx Xxxxx Xxxx 0000 Xxxx Xxxxx Xxxx
Xxxxxxxx, Xxxxxxxxxxxx 00000 Xxxxxxxx, Xxxxxxxxxxxx 00000
/s/ Xxxxxxx Xxxxxxxx /s/ Xxxxx Xxxxxxxx
------------------------------ ----------------------------------
XXXX XXXX XXXXXX XXXXX
c/o D.R. International 000 Xxxxxx Xxxx
0000 Xx. Xxxxxxxx Xxxxxx Xxxxxx, Xxxxxxxxxxxx 00000
Xxx Xxxxxxx, Xxxxxxxxxx 00000
/s/ Xxxx Xxxx /s/ Xxxxxx Xxxxx
------------------------------ ----------------------------------
-0-
XXXXXXX XXXX XXXXXX X. XXXXX & CO., INC., TTEE
c/o Xxxxxx Xxxx FBO Xxxxxxx X. Xxxxxxx XXX
000 Xxxx Xxxxxx c/x Xxxxxx Drug Co., Inc.
Xxx Xxxx, Xxx Xxxx 00000 000 Xxxxx Xxxxxxxxxx Xx.
Crimson Building #2
Rockford, Ill. 00000
/x/ Xxxxxxx Xxxx /s/ Xxxxxx X. Xxxxx
------------------------------ ----------------------------------
By: Xxxxxxx X. Xxxxxxx
Its: Trustee
XXXXXXX XXXXXXX XXXXX XXXXXXX
c/x Xxxxxx Drug Co., Inc. c/x Xxxxxx Drug Co., Inc.
000 Xxxxx Xxxxxxxxxx Xx. 000 Xxxxx Xxxxxxxxxx Xx.
Crimson Building #2 Crimson Building #2
Rockford, Ill. 61107 Xxxxxxxx, Xxx. 00000
/s/ Xxxxxxx Xxxxxxx /s/ Xxxxx Xxxxxxx
------------------------------ ----------------------------------
XXXXXX XXXXXXX TRUST XXXXXXXXX XXXXXXXXX
c/x Xxxxxx Drug Co., Inc. c/x Xxxxxx Drug Co., Inc.
000 Xxxxx Xxxxxxxxxx Xx. 000 Xxxxx Xxxxxxxxxx Xx.
Crimson Building #2 Crimson Building #2
Rockford, Ill. 61107 Xxxxxxxx, Xxx. 00000
/s/ Xxxxxx Xxxxxxx /s/ Xxxxxxxxx Xxxxxxxxx
------------------------------ ----------------------------------
By: Xxxxxx Xxxxxxx
Its: Trustee
XXXXXX X. XXXX XXXXXX X. XXXX
00 Xxxxxxx Xxxxx 00 Xxxxxxx Xxxxx
Xxxxxx, Xxx Xxxxxx 00000 Xxxxxx, Xxx Xxxxxx 00000
/s/ Xxxxxx X. Xxxx /s/ Xxxxxx X. Xxxx
------------------------------ ----------------------------------
XXXXXX X. XXXX AS CUSTODIAN XXXXXX X. XXXX AS CUSTODIAN
FOR XXXXXX X. XXXX FOR XXXXXX X. XXXX
00 Xxxxxxx Xxxxx 00 Xxxxxxx Xxxxx
Xxxxxx, Xxx Xxxxxx 00000 Xxxxxx, Xxx Xxxxxx 00000
/s/ Xxxxxx X. Xxxx /s/ Xxxxxx X. Xxxx
------------------------------ ----------------------------------
By: Varshah X. Xxxx By: Varshah X. Xxxx
Its: Custodian Its: Custodian
-10-
XXXXXXX XXXXXXXX XXXXX XXXXXXXX
c/o Xxxxx Xxxxxxxx c/o Xxxxx Xxxxxxxx
000 Xxxxx Xxxxx 000 Xxxxx Xxxxx
Xxxxxxxxxxx, Xxx Xxxxxx 00000 Xxxxxxxxxxx, Xxx Xxxxxx 00000
/s/ Xxxxxxx Xxxxxxxx /s/ Xxxxx Xxxxxxxx
------------------------------ ----------------------------------
XXXXXXX XXXXXX, XXX ACCOUNT XXXXXXX XXXXXX
FBO XXXXXXX XXXXXX 0000 Xxxxxxxxxx Xxxxxx
0000 Xxxxxxxxxx Xxxxxx Xxxxxxxx Xxxx, Xxx. 00000
Xxxxxxxx Xxxx, Xxx. 00000
/s/ Xxxxxxx Xxxxxx /s/ Xxxxxxx Xxxxxx
------------------------------ ----------------------------------
By: __________________________
Its: Trustee
XXXXXXX X. XXXXXXX XXXX X. XXXXXXX
c/x Xxxxxx Drug Co., Inc. c/x Xxxxxx Drug Co., Inc.
000 Xxxxx Xxxxxxxxxx Xx. 000 Xxxxx Xxxxxxxxxx Xx.
Crimson Building #2 Crimson Building #2
Rockford, Ill. 61107 Xxxxxxxx, Xxx. 00000
/s/ Xxxxxxx X. Xxxxxxx /s/ Xxxx X. Xxxxxxx
------------------------------ ----------------------------------
BROOKE XXXXX XXXXXXX ALEX XXXX XXXXXXX
c/x Xxxxxx Drug Co., Inc. c/x Xxxxxx Drug Co., Inc.
000 Xxxxx Xxxxxxxxxx Xx. 000 Xxxxx Xxxxxxxxxx Xx.
Crimson Building #2 Crimson Building #2
Rockford, Ill. 61107 Xxxxxxxx, Xxx. 00000
/s/ Brooke Xxxxx Xxxxxxx /s/ Alex Xxxx Xxxxxxx
------------------------------ ----------------------------------
XXXXXXXX XXXXX XXXXXXX XXXXX XXXXXXX
c/x Xxxxxx Drug Co., Inc. c/x Xxxxxx Drug Co., Inc.
000 Xxxxx Xxxxxxxxxx Xx. 000 Xxxxx Xxxxxxxxxx Xx.
Crimson Building #2 Crimson Building #2
Rockford, Ill. 61107 Xxxxxxxx, Xxx. 00000
/s/ Xxxxxxxx Xxxxx Xxxxxxx /s/ Xxxxx Xxxxxxx
------------------------------ ----------------------------------
-11-
XXXXXXX X. XXXXXXX XX XXXX XXXXX XXXXXXX
c/x Xxxxxx Drug Co., Inc. c/x Xxxxxx Drug Co., Inc.
000 Xxxxx Xxxxxxxxxx Xx. 000 Xxxxx Xxxxxxxxxx Xx.
Crimson Building #2 Crimson Building #2
Rockford, Ill. 61107 Xxxxxxxx, Xxx. 00000
/s/ Xxxxxxx X. Xxxxxxx /s/ Xxxx Xxxxx Xxxxxxx
------------------------------ ----------------------------------
XXXXXX X. XXXXX & CO., INC., TTEE XXXXXX X. XXXXX & CO., INC., TTEE
FBO Xxxxxxx Xxxxxxx XXX FBO Xxxxxx Xxxxxxx XXX
c/x Xxxxxx Drug Co., Inc. c/x Xxxxxx Drug Co., Inc.
000 Xxxxx Xxxxxxxxxx Xx. 000 Xxxxx Xxxxxxxxxx Xx.
Crimson Building #2 Crimson Building #2
Rockford, Ill. 61107 Xxxxxxxx, Xxx. 00000
/s/ Xxxxxx X. Xxxxx /s/ Xxxxxx X. Xxxxx
------------------------------ ----------------------------------
By: Xxxxxx X. Xxxxx By: Xxxxxx X. Xxxxx
Its: Trustee Its: Trustee
XXXXXXX XXXXXXX TRUST
c/x Xxxxxx Drug Co., Inc.
000 Xxxxx Xxxxxxxxxx Xx.
Crimson Building #2
Rockford, Ill. 61107
/s/ Xxxxxxx X. Xxxxxxx
------------------------------
By: Xxxxxxx X. Xxxxxxx
Its: Trustee
-12-
